nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethambutol—Optic nerve disorder—Fludarabine—lymphatic system cancer	0.0975	0.0975	CcSEcCtD
Ethambutol—Lung infiltration—Fludarabine—lymphatic system cancer	0.0281	0.0281	CcSEcCtD
Ethambutol—Blindness—Fludarabine—lymphatic system cancer	0.0238	0.0238	CcSEcCtD
Ethambutol—Optic neuritis—Fludarabine—lymphatic system cancer	0.0214	0.0214	CcSEcCtD
Ethambutol—Lung infiltration—Bleomycin—lymphatic system cancer	0.0206	0.0206	CcSEcCtD
Ethambutol—Lung infiltration—Carmustine—lymphatic system cancer	0.018	0.018	CcSEcCtD
Ethambutol—Numbness—Fludarabine—lymphatic system cancer	0.0159	0.0159	CcSEcCtD
Ethambutol—Sensory loss—Fludarabine—lymphatic system cancer	0.0152	0.0152	CcSEcCtD
Ethambutol—Blindness—Vincristine—lymphatic system cancer	0.0146	0.0146	CcSEcCtD
Ethambutol—Hepatic function abnormal—Teniposide—lymphatic system cancer	0.0125	0.0125	CcSEcCtD
Ethambutol—Scotoma—Carmustine—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Ethambutol—Neuritis—Vincristine—lymphatic system cancer	0.0108	0.0108	CcSEcCtD
Ethambutol—Liver function test abnormal—Teniposide—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Ethambutol—Numbness—Vincristine—lymphatic system cancer	0.00972	0.00972	CcSEcCtD
Ethambutol—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.00967	0.00967	CcSEcCtD
Ethambutol—Sensory loss—Vincristine—lymphatic system cancer	0.0093	0.0093	CcSEcCtD
Ethambutol—Pericarditis—Methotrexate—lymphatic system cancer	0.00904	0.00904	CcSEcCtD
Ethambutol—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.00884	0.00884	CcSEcCtD
Ethambutol—Neutropenia—Teniposide—lymphatic system cancer	0.00881	0.00881	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Fludarabine—lymphatic system cancer	0.00862	0.00862	CcSEcCtD
Ethambutol—Lung infiltration—Methotrexate—lymphatic system cancer	0.00834	0.00834	CcSEcCtD
Ethambutol—Neuropathy peripheral—Teniposide—lymphatic system cancer	0.00823	0.00823	CcSEcCtD
Ethambutol—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00797	0.00797	CcSEcCtD
Ethambutol—Disorientation—Bleomycin—lymphatic system cancer	0.00785	0.00785	CcSEcCtD
Ethambutol—Neutropenia—Fludarabine—lymphatic system cancer	0.00774	0.00774	CcSEcCtD
Ethambutol—Pneumonia—Fludarabine—lymphatic system cancer	0.00742	0.00742	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.00732	0.00732	CcSEcCtD
Ethambutol—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00726	0.00726	CcSEcCtD
Ethambutol—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.00723	0.00723	CcSEcCtD
Ethambutol—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00711	0.00711	CcSEcCtD
Ethambutol—Anorexia—Mechlorethamine—lymphatic system cancer	0.00692	0.00692	CcSEcCtD
Ethambutol—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00659	0.00659	CcSEcCtD
Ethambutol—Visual impairment—Fludarabine—lymphatic system cancer	0.00638	0.00638	CcSEcCtD
Ethambutol—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00631	0.00631	CcSEcCtD
Ethambutol—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00626	0.00626	CcSEcCtD
Ethambutol—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00589	0.00589	CcSEcCtD
Ethambutol—Leukopenia—Teniposide—lymphatic system cancer	0.00587	0.00587	CcSEcCtD
Ethambutol—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00566	0.00566	CcSEcCtD
Ethambutol—Pneumonia—Bleomycin—lymphatic system cancer	0.00544	0.00544	CcSEcCtD
Ethambutol—Confusional state—Teniposide—lymphatic system cancer	0.0054	0.0054	CcSEcCtD
Ethambutol—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00535	0.00535	CcSEcCtD
Ethambutol—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00535	0.00535	CcSEcCtD
Ethambutol—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00524	0.00524	CcSEcCtD
Ethambutol—Malaise—Fludarabine—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Ethambutol—Leukopenia—Fludarabine—lymphatic system cancer	0.00516	0.00516	CcSEcCtD
Ethambutol—Pruritus—Mechlorethamine—lymphatic system cancer	0.00514	0.00514	CcSEcCtD
Ethambutol—Anorexia—Teniposide—lymphatic system cancer	0.0051	0.0051	CcSEcCtD
Ethambutol—Neutropenia—Carmustine—lymphatic system cancer	0.00495	0.00495	CcSEcCtD
Ethambutol—Arthralgia—Fludarabine—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Ethambutol—Discomfort—Fludarabine—lymphatic system cancer	0.00485	0.00485	CcSEcCtD
Ethambutol—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00483	0.00483	CcSEcCtD
Ethambutol—Pneumonia—Carmustine—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Ethambutol—Confusional state—Fludarabine—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Ethambutol—Neutropenia—Vincristine—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Ethambutol—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00471	0.00471	CcSEcCtD
Ethambutol—Decreased appetite—Teniposide—lymphatic system cancer	0.00466	0.00466	CcSEcCtD
Ethambutol—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00463	0.00463	CcSEcCtD
Ethambutol—Vomiting—Mechlorethamine—lymphatic system cancer	0.00462	0.00462	CcSEcCtD
Ethambutol—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Ethambutol—Neutropenia—Mitoxantrone—lymphatic system cancer	0.0046	0.0046	CcSEcCtD
Ethambutol—Rash—Mechlorethamine—lymphatic system cancer	0.00458	0.00458	CcSEcCtD
Ethambutol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00458	0.00458	CcSEcCtD
Ethambutol—Pneumonia—Vincristine—lymphatic system cancer	0.00453	0.00453	CcSEcCtD
Ethambutol—Anorexia—Fludarabine—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Ethambutol—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Ethambutol—Pneumonia—Mitoxantrone—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Ethambutol—Feeling abnormal—Teniposide—lymphatic system cancer	0.00441	0.00441	CcSEcCtD
Ethambutol—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00438	0.00438	CcSEcCtD
Ethambutol—Nausea—Mechlorethamine—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Ethambutol—Abdominal pain—Teniposide—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Ethambutol—Body temperature increased—Teniposide—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Ethambutol—Paraesthesia—Fludarabine—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Ethambutol—Hallucination—Carmustine—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Ethambutol—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Ethambutol—Decreased appetite—Fludarabine—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Ethambutol—Visual impairment—Carmustine—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Ethambutol—Hallucination—Vincristine—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Ethambutol—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Ethambutol—Hypersensitivity—Teniposide—lymphatic system cancer	0.00395	0.00395	CcSEcCtD
Ethambutol—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Ethambutol—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Ethambutol—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Ethambutol—Malaise—Bleomycin—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Ethambutol—Pruritus—Teniposide—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Ethambutol—Leukopenia—Bleomycin—lymphatic system cancer	0.00378	0.00378	CcSEcCtD
Ethambutol—Body temperature increased—Fludarabine—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Ethambutol—Discomfort—Bleomycin—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Ethambutol—Confusional state—Bleomycin—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Ethambutol—Vision blurred—Carmustine—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Ethambutol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Ethambutol—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Ethambutol—Vomiting—Teniposide—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Ethambutol—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Ethambutol—Rash—Teniposide—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Ethambutol—Dermatitis—Teniposide—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Ethambutol—Headache—Teniposide—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Ethambutol—Pruritus—Fludarabine—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Ethambutol—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Ethambutol—Leukopenia—Carmustine—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Ethambutol—Anorexia—Bleomycin—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Ethambutol—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Ethambutol—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Ethambutol—Nausea—Teniposide—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Ethambutol—Leukopenia—Vincristine—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Ethambutol—Paraesthesia—Bleomycin—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Ethambutol—Malaise—Mitoxantrone—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Ethambutol—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Ethambutol—Confusional state—Carmustine—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Ethambutol—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Ethambutol—Decreased appetite—Bleomycin—lymphatic system cancer	0.003	0.003	CcSEcCtD
Ethambutol—Vomiting—Fludarabine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Ethambutol—Rash—Fludarabine—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Ethambutol—Dermatitis—Fludarabine—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Ethambutol—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Ethambutol—Headache—Fludarabine—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Ethambutol—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Ethambutol—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Ethambutol—Discomfort—Mitoxantrone—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Ethambutol—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Ethambutol—Anorexia—Carmustine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Ethambutol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Ethambutol—Confusional state—Mitoxantrone—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Ethambutol—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Ethambutol—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Ethambutol—Nausea—Fludarabine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Ethambutol—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Ethambutol—Anorexia—Vincristine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Ethambutol—Body temperature increased—Bleomycin—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Ethambutol—Paraesthesia—Carmustine—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Ethambutol—Anorexia—Mitoxantrone—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Ethambutol—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Ethambutol—Decreased appetite—Carmustine—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Ethambutol—Paraesthesia—Vincristine—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Ethambutol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Ethambutol—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Ethambutol—Decreased appetite—Vincristine—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Ethambutol—Feeling abnormal—Carmustine—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Ethambutol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Ethambutol—Pruritus—Bleomycin—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Ethambutol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Ethambutol—Eosinophilia—Methotrexate—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Ethambutol—Body temperature increased—Carmustine—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Ethambutol—Abdominal pain—Carmustine—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Ethambutol—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Ethambutol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Ethambutol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Ethambutol—Neutropenia—Methotrexate—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Ethambutol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Ethambutol—Body temperature increased—Vincristine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Ethambutol—Abdominal pain—Vincristine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Ethambutol—Hypersensitivity—Carmustine—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Ethambutol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Ethambutol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Ethambutol—Pneumonia—Methotrexate—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Ethambutol—Vomiting—Bleomycin—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Ethambutol—Rash—Bleomycin—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Ethambutol—Dermatitis—Bleomycin—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Ethambutol—Hypersensitivity—Vincristine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Ethambutol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Ethambutol—Nausea—Bleomycin—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Ethambutol—Dizziness—Carmustine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Ethambutol—Hepatitis—Methotrexate—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Ethambutol—Vomiting—Carmustine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Ethambutol—Dizziness—Vincristine—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Ethambutol—Rash—Carmustine—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Ethambutol—Dermatitis—Carmustine—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Ethambutol—Visual impairment—Methotrexate—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Ethambutol—Headache—Carmustine—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Ethambutol—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Ethambutol—Vomiting—Vincristine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Ethambutol—Rash—Vincristine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Ethambutol—Dermatitis—Vincristine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Ethambutol—Headache—Vincristine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Ethambutol—Nausea—Carmustine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Ethambutol—Vomiting—Mitoxantrone—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Ethambutol—Rash—Mitoxantrone—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Ethambutol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Ethambutol—Headache—Mitoxantrone—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Ethambutol—Nausea—Vincristine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Ethambutol—Nausea—Mitoxantrone—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Ethambutol—Vision blurred—Methotrexate—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Ethambutol—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Ethambutol—Malaise—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Ethambutol—Leukopenia—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Ethambutol—Arthralgia—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Ethambutol—Discomfort—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Ethambutol—Confusional state—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Ethambutol—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Ethambutol—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Ethambutol—Anorexia—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Ethambutol—Paraesthesia—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Ethambutol—Decreased appetite—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Ethambutol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Ethambutol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Ethambutol—Body temperature increased—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Ethambutol—Abdominal pain—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Ethambutol—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Ethambutol—Pruritus—Methotrexate—lymphatic system cancer	0.000987	0.000987	CcSEcCtD
Ethambutol—Dizziness—Methotrexate—lymphatic system cancer	0.000923	0.000923	CcSEcCtD
Ethambutol—Vomiting—Methotrexate—lymphatic system cancer	0.000887	0.000887	CcSEcCtD
Ethambutol—Rash—Methotrexate—lymphatic system cancer	0.00088	0.00088	CcSEcCtD
Ethambutol—Dermatitis—Methotrexate—lymphatic system cancer	0.000879	0.000879	CcSEcCtD
Ethambutol—Headache—Methotrexate—lymphatic system cancer	0.000874	0.000874	CcSEcCtD
Ethambutol—Nausea—Methotrexate—lymphatic system cancer	0.000829	0.000829	CcSEcCtD
